Risperidone for Substance Dependent Psychotic Patients

被引:4
|
作者
Poling, James
Kosten, Thomas R.
机构
[1] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[2] VISN 1 Mental Illness Res Educ & Clin Ctr, West Haven, CT USA
来源
关键词
risperidone; substance use disorders; schizophrenia; cannabis; stimulants;
D O I
10.1097/00132576-200503000-00001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: This study examined urine toxicology results at a single VA clinic in psychotic veterans with substance use disorders before and after switching to risperidone. Methods: In FY1995-2000, 104 psychotic veterans with substance use disorders (SUD) switched to risperidone (0.5-4 mg) and had urine toxicologies (avg 18) documenting opiate, cocaine, or marijuana use for at least 3 months before and after switching. Results: The rate of illicit urines was significantly higher before than after switching to risperidone (38% vs. 29%) (cocaine 19% to 15%; cannabis 13% to 10%). Conclusions: Urine toxicologies in a sample of veterans showed that risperidone was associated with a modest reduction in a range of illicit drugs over a period of 3 months before and after a medication switch.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [41] Long-acting risperidone improves negative symptoms in stable psychotic patients
    Curtis, V. A.
    Katsafouros, K.
    Moeller, H. J.
    Medori, R.
    Sacchetti, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S151 - S151
  • [42] Risperidone improves psychotic symptoms in elderly patients with dementia-related psychosis
    Brodaty, H
    DeDeyn, PP
    Lyons, B
    Ko, G
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1058 - 1058
  • [43] Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders
    Eberhard, J.
    Lindstrom, E.
    Holstad, M.
    Levander, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2007, 115 (04) : 268 - 276
  • [45] Acute mania and psychotic symptoms in bipolar patients: The efficacy of treatment with risperidone and olanzapine
    Basi, C
    Gambini, O
    Luoni, A
    Corbetta, A
    Scarone, S
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 143 - 143
  • [46] Long-acting risperidone improves negative symptoms in stable psychotic patients
    Curtis, V. A.
    Katsafouros, K.
    Moeller, H.-J.
    Medori, R.
    Sacchetti, E.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (03) : 254 - 261
  • [47] Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone
    Kufferle, B
    Brucke, T
    TopitzSchratzberger, A
    Tauscher, J
    Gossler, R
    Vesely, C
    Asenbaum, S
    Podreka, I
    Kasper, S
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1996, 68 (01) : 23 - 30
  • [48] Stable elderly patients with psychotic disorders improve with long-acting risperidone
    Lasser, R
    Bossie, C
    Eerdekens, M
    Zhu, Y
    Gharabawi, G
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 342 - 342
  • [49] Risperidone oral solution, therapeutic possibility in treatment of acute and agitated psychotic patients
    Lasic, D.
    Rubesa, G.
    Dodig, G.
    Katavic, Z.
    Glavina, T.
    Zuljan-Cvitanovic, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S445 - S446
  • [50] Improved outcome in psychotic patients treated with risperidone long acting injectable: Experience in German patients
    Moeller, H
    Schreiner, A
    Kissling, W
    Naber, D
    Schmauss, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S236 - S236